| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 17 |
| 1 | LEVOFLOXACIN | 15 |
| 2 | LEVOFLOXACIN IN 5% DEXTROSE | 15 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 15 |
| 4 | TACROLIMUS OINTMENT 0.1% | 15 |
| 5 | FLUCONAZOLE | 12 |
| 6 | FLUDARABINE PHOSPHATE | 12 |
| 7 | BUSULFAN | 11 |
| 8 | FOSPHENYTOIN SODIUM | 11 |
| 9 | ACYCLOVIR | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSPHENYTOIN SODIUM | 11 | 0.0043 |
| 1 | CISATRACURIUM BESYLATE | 4 | 0.0018 |
| 2 | ETHOSUXIMIDE | 3 | 0.0012 |
| 3 | BUSULFAN | 11 | 0.0007 |
| 4 | NITRIC OXIDE | 3 | 0.0006 |
| 5 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 4 | 0.0005 |
| 7 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 8 | PHENOBARBITAL | 6 | 0.0004 |
| 9 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | General Anesthetic [EPC] | 10 | 0.0002 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 15 | 0.0001 |
| 5 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 7 | Macrolide Antimicrobial [EPC] | 5 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0001 |